For help on how to get the results you want, see our search tips.
37 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Referral: Crestor and associated names
rosuvastatin, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 30/06/2014, -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, -
List item
Referral: Yaz 24+4
ethinylestradiol / drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid / valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, -
List item
Referral: Novimp
goserelin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, -
List item
Referral: Goserelin Cell Pharm
goserelin, associated names: Novosis Goserelin, Goserelin Cell Pharm, Novimp and associated names, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, -
List item
Referral: Novosis Goserelin
goserelin, associated names: Goserelin Novosis, Gosacin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, -
List item
Referral: Cozaar
irbesartan, associated names: Loortan, Loortan Cardio Start, Cozaar Startpakkle, Cardopal Start, Lorzaar, Lorzaar start, Lorzaar Protect, Pinzaar, Lorzaar Varipharmstart, Lortaan, Neo-Lotan, Losaprex, Cozaar IC, Lortaar IC, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 23/10/2008, EC decision date: 22/01/2009, -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, -
List item
Referral: Sortis
atorvastatin, associated names: Lipitor, Zarator, Orbeos, Tahor, Liprimar, Atorvastatin, Atorvastatina, Edovin, Obradon, Xarator, Torvast, Totalip, Texzor, Cardyl, Prevencor, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 01/07/2010, -
List item
Referral: Genotropin
somatropin, associated names: Genotonorm, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 02/09/2010, -
List item
Referral: Xalatan
latanoprost, associated names: Latanoprost Pharmacia & Upjohn, Xalatan 50 mikrogramov/ml kaplijice za oko, raztopina, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 15/10/2010, -
List item
Referral: Diovan
valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Kalpress, Miten, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, -
List item
Referral: Diovan
valsartan, associated names: Angiosan, Diovane, Tareg, Cordinate, Provas, Dalzad, Rixil, Kalpress Cardio, Diovan Cardio, Miten Cardio, Valsartan Novartis, Article 29 paediatrics
Status: European Commission final decision, opinion/position date: 15/12/2009, EC decision date: 19/04/2010, -
List item
Referral: Arimidex
anastrozole, Article 29 paediatrics
Status: European Commission final decision, EC decision date: 06/11/2009, -
List item
Referral: Extraneal
icodextrin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 20/01/2010, -
List item
Referral: Arcoxia
etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, -
List item
Referral: Avelox
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, -
List item
Referral: Octegra
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, -
List item
Referral: Actira
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, -
List item
Referral: Gadograf, Gadovist
gadobutrol, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 13/04/2007, -
List item
Referral: Sortis
atorvastatin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/03/2006, EC decision date: 22/05/2006, -
List item
Referral: Prozac
Fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, -
List item
Referral: Coversyl
Perindopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2005, EC decision date: 07/11/2005,